Title : Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.

Pub. Date : 2017 Aug 30

PMID : 28771277






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 At baseline, the prothrombin mutation group formed denser clots (Ks -12 %, p=0.0006) and had impaired fibrinolysis (CLT +14 %, p=0.004, and CLT-TAFI +13 %, p=0.03) compared with the no mutation group and were similar to those observed in 15 healthy unrelated prothrombin mutation carriers. Potassium coagulation factor II, thrombin Homo sapiens